Cargando…

Indocyanine Green Clearance Test for the Preoperative Assessment of Chemotherapy-Related Hepatic Injury in Patients with Colorectal Liver Metastasis

PURPOSE: The aim of the present study was to determine the value of the indocyanine green (ICG) clearance test in the preoperative assessment of chemotherapy-related hepatic injury in patients with liver metastasis from colorectal cancer. METHODS: A total of 218 patients who underwent hepatic dissec...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Li-Jun, Yan, Xiao-Luan, Li, Juan, Wang, Kun, Xing, Bao-Cai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217306/
https://www.ncbi.nlm.nih.gov/pubmed/32440220
http://dx.doi.org/10.2147/CMAR.S252693
_version_ 1783532589824344064
author Wang, Li-Jun
Yan, Xiao-Luan
Li, Juan
Wang, Kun
Xing, Bao-Cai
author_facet Wang, Li-Jun
Yan, Xiao-Luan
Li, Juan
Wang, Kun
Xing, Bao-Cai
author_sort Wang, Li-Jun
collection PubMed
description PURPOSE: The aim of the present study was to determine the value of the indocyanine green (ICG) clearance test in the preoperative assessment of chemotherapy-related hepatic injury in patients with liver metastasis from colorectal cancer. METHODS: A total of 218 patients who underwent hepatic dissection due to colorectal cancer liver metastasis at the Peking University Cancer Hospital between January 2016 and December 2017 were retrospectively evaluated; 179 patients who received chemotherapy prior to hepatic resection were further examined. Patient- and chemotherapy-related factors were analyzed in both groups with normal and abnormal ICG retention rate at 15 min (ICG-R15), and their intraoperative and postoperative outcomes were compared. RESULTS: The chemotherapy group had a higher mean ICG-R15 value and a higher number of patients who exhibited abnormal ICG-R15, compared with the no-chemotherapy group. Under the guidance of ICG test, no patients experienced severe complications in the abnormal ICG-R15 group compared with the normal ICG-R15 group, and the overall morbidity was also not significantly different between the two groups. However, the incidence of severe complications was higher in patients who underwent major resection with a normal ICG-R15 value compared with patients with an abnormal ICG-R15 value who underwent minor resection (P<0.05). Multivariable logistic regression analyses revealed that body mass index (BMI) ≥28 and oxaliplatin use were independent predictors of abnormal ICG-R15. The ICG-R15 value was significantly higher in the two-risk factors group compared with the no-risk factor group (P=0.012), but not statistically different compared with the one risk factor group. CONCLUSION: Screening of patients with chemotherapy-associated liver injury using the IGC test may help in performing safe hepatectomy by avoiding major resection. BMI ≥28 and oxaliplatin use were independent preoperative predictors of abnormal ICG-R15.
format Online
Article
Text
id pubmed-7217306
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-72173062020-05-21 Indocyanine Green Clearance Test for the Preoperative Assessment of Chemotherapy-Related Hepatic Injury in Patients with Colorectal Liver Metastasis Wang, Li-Jun Yan, Xiao-Luan Li, Juan Wang, Kun Xing, Bao-Cai Cancer Manag Res Original Research PURPOSE: The aim of the present study was to determine the value of the indocyanine green (ICG) clearance test in the preoperative assessment of chemotherapy-related hepatic injury in patients with liver metastasis from colorectal cancer. METHODS: A total of 218 patients who underwent hepatic dissection due to colorectal cancer liver metastasis at the Peking University Cancer Hospital between January 2016 and December 2017 were retrospectively evaluated; 179 patients who received chemotherapy prior to hepatic resection were further examined. Patient- and chemotherapy-related factors were analyzed in both groups with normal and abnormal ICG retention rate at 15 min (ICG-R15), and their intraoperative and postoperative outcomes were compared. RESULTS: The chemotherapy group had a higher mean ICG-R15 value and a higher number of patients who exhibited abnormal ICG-R15, compared with the no-chemotherapy group. Under the guidance of ICG test, no patients experienced severe complications in the abnormal ICG-R15 group compared with the normal ICG-R15 group, and the overall morbidity was also not significantly different between the two groups. However, the incidence of severe complications was higher in patients who underwent major resection with a normal ICG-R15 value compared with patients with an abnormal ICG-R15 value who underwent minor resection (P<0.05). Multivariable logistic regression analyses revealed that body mass index (BMI) ≥28 and oxaliplatin use were independent predictors of abnormal ICG-R15. The ICG-R15 value was significantly higher in the two-risk factors group compared with the no-risk factor group (P=0.012), but not statistically different compared with the one risk factor group. CONCLUSION: Screening of patients with chemotherapy-associated liver injury using the IGC test may help in performing safe hepatectomy by avoiding major resection. BMI ≥28 and oxaliplatin use were independent preoperative predictors of abnormal ICG-R15. Dove 2020-05-08 /pmc/articles/PMC7217306/ /pubmed/32440220 http://dx.doi.org/10.2147/CMAR.S252693 Text en © 2020 Wang et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Wang, Li-Jun
Yan, Xiao-Luan
Li, Juan
Wang, Kun
Xing, Bao-Cai
Indocyanine Green Clearance Test for the Preoperative Assessment of Chemotherapy-Related Hepatic Injury in Patients with Colorectal Liver Metastasis
title Indocyanine Green Clearance Test for the Preoperative Assessment of Chemotherapy-Related Hepatic Injury in Patients with Colorectal Liver Metastasis
title_full Indocyanine Green Clearance Test for the Preoperative Assessment of Chemotherapy-Related Hepatic Injury in Patients with Colorectal Liver Metastasis
title_fullStr Indocyanine Green Clearance Test for the Preoperative Assessment of Chemotherapy-Related Hepatic Injury in Patients with Colorectal Liver Metastasis
title_full_unstemmed Indocyanine Green Clearance Test for the Preoperative Assessment of Chemotherapy-Related Hepatic Injury in Patients with Colorectal Liver Metastasis
title_short Indocyanine Green Clearance Test for the Preoperative Assessment of Chemotherapy-Related Hepatic Injury in Patients with Colorectal Liver Metastasis
title_sort indocyanine green clearance test for the preoperative assessment of chemotherapy-related hepatic injury in patients with colorectal liver metastasis
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217306/
https://www.ncbi.nlm.nih.gov/pubmed/32440220
http://dx.doi.org/10.2147/CMAR.S252693
work_keys_str_mv AT wanglijun indocyaninegreenclearancetestforthepreoperativeassessmentofchemotherapyrelatedhepaticinjuryinpatientswithcolorectallivermetastasis
AT yanxiaoluan indocyaninegreenclearancetestforthepreoperativeassessmentofchemotherapyrelatedhepaticinjuryinpatientswithcolorectallivermetastasis
AT lijuan indocyaninegreenclearancetestforthepreoperativeassessmentofchemotherapyrelatedhepaticinjuryinpatientswithcolorectallivermetastasis
AT wangkun indocyaninegreenclearancetestforthepreoperativeassessmentofchemotherapyrelatedhepaticinjuryinpatientswithcolorectallivermetastasis
AT xingbaocai indocyaninegreenclearancetestforthepreoperativeassessmentofchemotherapyrelatedhepaticinjuryinpatientswithcolorectallivermetastasis